Thursday, 25 February 2021

Hyderabad to identify and nurture best startups in diagnostics space

08 February 2021 | News

RICH aims to transform the scientific start-up ecosystem, by focusing on enabling inventions and innovations to reach the market



Research and Innovation Circle of Hyderabad (RICH) is inviting applications for their startup accelerator programme from promising startups and entrepreneurs wishing to fast-track their diagnostic product to market.

Backed by the Government of Telangana, and the Office of Principal Scientific Adviser to the Government of India – RICH aims to transform the scientific start-up ecosystem, by focusing on enabling inventions and innovations to reach the market.

“Innovation in Science has demonstrated its ability to transform the world. In diagnostics, Indian scientists, engineers, and data experts are rapidly innovating new products that can help humanity to identify and overcome many diseases expeditiously. We will give the best among them, the full complement of support to help them succeed,” says Ajit Rangnekar, Director General, RICH.

AID is conceived by RICH as a multi-stakeholder alliance whose goal is to identify and nurture the best start-ups in the diagnostics space. Mentored by an expert panel of entrepreneurs, scientists, inventors, and innovators; supported by the Centre for Cellular and Molecular Biology (CCMB), Hyderabad – AID is expected to help start-ups overcome all hurdles – both conceptual and infrastructural - to realise their full potential.

As part of the AID program, RICH is currently inviting applications from start-ups, entrepreneurs, researchers, and academic institutions in the in vitro diagnostics sector for their accelerator programme. The programme is open to start-ups with a completed proof of concept, and rewards are priceless.

The applications will be evaluated by a panel constituting thematic experts and industry leaders. The most promising start-ups selected by the panel will gain the golden opportunity to undergo incubation at premier research institutes like CCMB.

The deadline for applications to the AID programme is February 17, 2021.


× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account

Survey Box

Should we be cautious of viewing COVID-19 vaccine as silver bullet?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls